Approach to the patient with acute severe autoimmune hepatitis
This 2020 review provides a structured approach to diagnosing and managing acute severe autoimmune hepatitis (AS-AIH), characterized by acute onset, jaundice, and an INR ≥1.5 without hepatic encephalopathy. The authors emphasize early recognition and prompt initiation of high-dose corticosteroids to prevent progression to acute liver failure. Liver biopsy is crucial